EUVIMEDEUVIMED entdecken
Crossref

NSUN6-mediated m5C RNA methylation aggravate osteosarcoma progression through promoting PKP2 mRNA stability and expression

Chunyan Zhao, Yun Tang, Yongpeng He, Fagen Zhang, Wenqian Li, Xiaochun Chen, Zhengyang Yu, Kaiwen Fu

Bone · 2026-06 · 207 · 117832

DOI: 10.1016/j.bone.2026.117832 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2026-06. Verfasst von Chunyan Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory, Yibin Hospital of Children's Hospital Affiliated to Chongqing Medical University, Yibin, Sichuan, 644000, China. Hauptthemen laut MEDLINE: Osteosarcoma, Plakophilins, Methyltransferases, RNA Stability. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Osteosarcoma (OS) is a highly aggressive malignant bone tumor with poor prognosis. Both Plakophilin 2 (PKP2) and NOP2/Sun RNA methyltransferase 6 (NSUN6) were reported to be upregulated in OS, and NSUN6 is one of the important RNA methyltransferases catalyzing 5-methylcytosine (m5C) formation and participates in many critical bioprocesses in various tumors. However, the roles and underlying molecular mechanisms of NSUN6-mediated m5C modification in OS remain unclear. METHODS: Differentially expressed genes in OS and the expression of PKP2 were analyzed using the GSE126209 dataset of the GEO database. The mRNA and protein levels of PKP2 as well as NSUN6 in OS tissues and cells were then measured by RT-qPCR and western blot. Then, the relationship between the expression of PKP2 and the survival rate of OS patients was presented by the Kaplan-Meier (KM) survival curve. Subsequently, OS cell proliferation, migration, and apoptosis were assessed by colony formation, Transwell, and flow cytometry. Meanwhile, the mitochondrial membrane potential, the levels of MDA, ROS, and Fe2+ was determined by the corresponding kits. Besides, the binding of PKP2 and NSUN6 was verified by RIP assay. Dot blot and Me-RIP assay were used to evaluate the 5-methylcytosine (m5C) modification level of PKP2. Finally, a xenograft model was constructed to investigate the role of NSUN6/PKP2 axis in vivo. RESULTS: PKP2 was highly expressed in OS tissues and cells. PKP2 knockdown could effectively inhibit the proliferation and migration of OS cells, and promote their apoptosis, oxidative stress and ferroptosis. NSUN6 stabilized PKP2 expression through m5C methylation modification. Moreover, overexpression of PKP2 effectively reversed the effects of NSUN6 knockdown on OS cells and xenograft tumors in mice. CONCLUSION: NSUN6 regulated the m5C methylation modification of PKP2 to stabilize its expression, thereby driving the malignant progression of OS cells, providing a promising targeted therapeutic strategy for OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaPlakophilinsMethyltransferasesRNA StabilityDisease ProgressionBone NeoplasmsHumansRNA MethylationCell Line, TumorAnimalsCell ProliferationGene Expression Regulation, NeoplasticRNA, MessengerApoptosisCell MovementMiceFemaleMice, Nude5-MethylcytosineMale

Stichwörter der Autor:innen

FerroptosisNOP2/Sun RNA methyltransferase 6OsteosarcomaOxidative stressPlakophilin 2m5C methylation modification

Substanzen

PlakophilinsMethyltransferasesRNA, Messenger5-Methylcytosine

Autor:innen und Institutionen

  • Department of Medical Laboratory, Yibin Hospital of Children's Hospital Affiliated to Chongqing Medical University, Yibin, Sichuan, 644000, China.
  • Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, 400030, China.
  • Department of Oncology, the First People's Hospital of Yibin, Yibin, Sichuan Province, 644000, China.
  • Department of Foot and Ankle Surgery, Chongqing Orthopedic Hospital of Traditional Chinese Medicine & The People's Hospital of Chongqing Yuzhong District & Chongqing Institute of Orthopedics of Traditional Chinese Medic…
  • Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, 400030, China. Electronic addre…

Zitieren

APA

Zhao, C., Tang, Y., He, Y., Zhang, F., Li, W., Chen, X., Yu, Z., & Fu, K. (2026). NSUN6-mediated m5C RNA methylation aggravate osteosarcoma progression through promoting PKP2 mRNA stability and expression. Bone, 207, 117832. https://doi.org/10.1016/j.bone.2026.117832

Vancouver

Zhao C, Tang Y, He Y, Zhang F, Li W, Chen X, et al. NSUN6-mediated m5C RNA methylation aggravate osteosarcoma progression through promoting PKP2 mRNA stability and expression. Bone. 2026;207:117832. doi:10.1016/j.bone.2026.117832

BibTeX
@article{Zhao2026,
  author = {Zhao, Chunyan and Tang, Yun and He, Yongpeng and Zhang, Fagen and Li, Wenqian and Chen, Xiaochun and Yu, Zhengyang and Fu, Kaiwen},
  title = {NSUN6-mediated m5C RNA methylation aggravate osteosarcoma progression through promoting PKP2 mRNA stability and expression},
  journal = {Bone},
  year = {2026},
  volume = {207},
  pages = {117832},
  doi = {10.1016/j.bone.2026.117832}
}
Kostenlos starten →